Bio-Reference Laboratories (BRLI) announces a 1M share stock buyback program to run through Oct. 31 of next year after shares cratered on corruption allegations. Shares are now down 20.7% after bottoming out at a 52-week low of $11.41 earlier.
From other sites
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs